Evidence map›Paper›PMID 36828383›Full record

ArticleTomography (Ann Arbor, Mich.)2023

[

Lighea Simona Airò Farulla, Laura Lavinia Travaini, Mariarosaria Cuomo, Domenico Galetta, Francesco Mattana, Samuele Frassoni, Giuseppe Buonsanti, Lorenzo Muraglia, Giulia Anna Zuccotti, Vincenzo Bagnardi and 2 more

Open access · goldAbstract read
In one paragraph

Article in Tomography (Ann Arbor, Mich.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Lighea Simona Airò FarullaDivision of Nuclear Medicine, IEO European Institute of Oncology, IRCCS, 20141 Milan, Italy.ORCID 0000-0003-3540-258X
Laura Lavinia TravainiDivision of Nuclear Medicine, IEO European Institute of Oncology, IRCCS, 20141 Milan, Italy.ORCID 0000-0002-8084-5649
Mariarosaria CuomoDivision of Nuclear Medicine, IEO European Institute of Oncology, IRCCS, 20141 Milan, Italy.
Domenico GalettaDepartment of Oncology and Hemato-Oncology, University of Milan, 20141 Milan, Italy.ORCID 0000-0003-4040-7211
Francesco MattanaDivision of Nuclear Medicine, IEO European Institute of Oncology, IRCCS, 20141 Milan, Italy.
Samuele FrassoniDepartment of Statistics and Quantitative Methods, University of Milan-Bicocca, 20141 Milan, Italy.ORCID 0000-0002-4265-2627
Giuseppe BuonsantiDivision of Nuclear Medicine, IEO European Institute of Oncology, IRCCS, 20141 Milan, Italy.
Lorenzo MuragliaDivision of Nuclear Medicine, IEO European Institute of Oncology, IRCCS, 20141 Milan, Italy.ORCID 0000-0002-8508-8368
Giulia Anna ZuccottiDivision of Nuclear Medicine, IEO European Institute of Oncology, IRCCS, 20141 Milan, Italy.
Vincenzo BagnardiDepartment of Statistics and Quantitative Methods, University of Milan-Bicocca, 20141 Milan, Italy.
Lorenzo SpaggiariDepartment of Oncology and Hemato-Oncology, University of Milan, 20141 Milan, Italy.
Francesco CeciDivision of Nuclear Medicine, IEO European Institute of Oncology, IRCCS, 20141 Milan, Italy.
University of Milan · ITEuropean Institute of Oncology · ITUniversity of Milano-Bicocca · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Renal Cell Carcinoma (RCC) is generally characterized by low-FDG avidity, and [

Indexed as

Carcinoma, Renal CellKidney NeoplasmsLung NeoplasmsFluorodeoxyglucose F18HumansLungPositron Emission Tomography Computed TomographyRetrospective StudiesTomography, X-Ray ComputedFluorodeoxyglucose F18FDGlung nodulePETrenal cell carcinoma

Identifiers

PMID36828383
PMCPMC9962353
OpenAlexW4319962709

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.